Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

57.38
BATS BZX Real-Time Price
As of 3:34pm ET
 +0.35 / +0.61%
Today’s Change
46.43
Today|||52-Week Range
63.40
+4.84%
Year-to-Date

Today’s Trading

Previous close57.03
Today’s open57.24
Day’s range57.01 - 58.18
Volume21,347
Average volume (3 months)911,851
Market cap$8.8B
Data as of 3:34pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+195.21%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.19

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+6.15+4.93%
SGENSeattle Genetics Inc+2.49+4.66%
TSROTESARO Inc+4.28+6.70%
JAZZJazz Pharmaceuticals...+2.69+1.81%
Data as of 3:34pm ET, 01/22/2018

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$0.21
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts